Transformed Non-Hodgkin Lymphoma — Trials

Transformed Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

75 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 2%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05377827	Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies	suspended	Phase 1	6	Washington University School of MedicineOTHER	1	Jul 21, 2026	clinicaltrials
NCT03704714	Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma	suspended	Phase 1 / Phase 2	30	Northwestern UniversityOTHER	1	Aug 15, 2022